Protagenic Therapeutics Files 8-K for Other Event
Ticker: PTIXW · Form: 8-K · Filed: Dec 3, 2024 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | Dec 3, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $2,500,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, other-event
Related Tickers: PTIX
TL;DR
PTIX filed an 8-K for an 'Other Event' on Nov 29, but details are scarce.
AI Summary
Protagenic Therapeutics, Inc. filed an 8-K on November 29, 2024, reporting an "Other Event." The filing does not contain specific details about the event, its financial implications, or any associated parties. The company, formerly known as Atrinsic, Inc., is incorporated in Delaware and headquartered in New York.
Why It Matters
This filing indicates a material event has occurred for Protagenic Therapeutics, but the lack of detail requires further investigation to understand its significance.
Risk Assessment
Risk Level: medium — The medium risk level is due to the filing of an 8-K, which typically signifies a material event, but the lack of specific information in this filing creates uncertainty.
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer
- November 29, 2024 (date) — Date of Earliest Event Reported
- Atrinsic, Inc. (company) — Former Company Name
- Delaware (jurisdiction) — State of Incorporation
- New York (location) — Company Headquarters
FAQ
What specific event is Protagenic Therapeutics, Inc. reporting in this 8-K filing?
The filing is categorized under "Other Events" and does not provide specific details about the event itself.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on November 29, 2024.
What is the company's state of incorporation?
The company is incorporated in Delaware.
What were some of Protagenic Therapeutics, Inc.'s former company names?
The company was formerly known as Atrinsic, Inc., NEW MOTION, INC., and MPLC, Inc.
What is the SEC file number for this filing?
The SEC file number is 001-12555.
Filing Stats: 556 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2024-12-03 07:20:40
Key Financial Figures
- $2,500,000 — pany") that it did not meet the minimum $2,500,000 stockholders' equity requirement for co
Filing Documents
- form8-k.htm (8-K) — 43KB
- 0001493152-24-048431.txt ( ) — 260KB
- ptix-20241129.xsd (EX-101.SCH) — 4KB
- ptix-20241129_def.xml (EX-101.DEF) — 29KB
- ptix-20241129_lab.xml (EX-101.LAB) — 36KB
- ptix-20241129_pre.xml (EX-101.PRE) — 26KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROTAGENIC THERAPEUTICS, INC. Date: December 3, 2024 By: /s/ Alexander K. Arrow Name: Alexander K. Arrow Title: Chief Financial Officer